Upholding a 2014 appeals court decision, the U.S. Supreme Court this week ruled that active market participants sitting on state regulatory boards must be closely supervised by the state, due to antitrust concerns.

Antitrust partner Michael Sibarium spoke to HealthLeaders Media, emphasizing the need for regulatory boards to review their structure and potential liability in light of the ruling — click here to read the full article.